Reversine
Appearance
![]() | |
Names | |
---|---|
IUPAC name
N′-Cyclohexyl-N-(4-morpholinophenyl)-7H-purine-2,6-diamine
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEBI | |
ChemSpider | |
ECHA InfoCard
|
100.164.070 |
MeSH | C484369 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
SMILES
| |
Properties | |
C21H27N7O | |
Molar mass | 393.495 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Reversine, or 2-(4-morpholinoanilino)-6-cyclohexylaminopurine, is a small molecule developed by the group of Peter G. Schultz, used for stem cell dedifferentiation.[1][2]
It also has the potential to selectively induce cell death in cancer cells.[3]
Reversine is known to act as an
A3 receptor. Reversine is a potent inhibitor of the mitotic kinase Mps1[4] and it is widely used to study the process of chromosome segregation
.
References
External links
- Henry, Celia (January 5, 2004). "Cellular U-Turn". Chemical and Engineering News. 82 (1): 9. .